Tocolytic Therapy for Acute Preterm Labor

Obstetrics and Gynecology Clinics of North America

Volumn 39, Issue 1, 2012, Pages 77-87

  Abramovici, Adi ^a   Cantu, Jessica ^a   Jenkins, Sheri M ^a  

^a Division of Maternal Fetal Medicine   (United States)

Author keywords

Beta mimetics; Calcium channel blockers; Magnesium sulfate; Oxytocin receptor antagonist; Preterm labor; Prostaglandin inhibitors; Tocolytic therapy

Indexed keywords

ATOSIBAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CELECOXIB; HEXOPRENALINE; INDOMETACIN; MAGNESIUM SULFATE; NIFEDIPINE; OXYTOCIN RECEPTOR ANTAGONIST; PLACEBO; PROSTAGLANDIN INHIBITOR; RITODRINE; ROFECOXIB; SALBUTAMOL; TERBUTALINE; UNCLASSIFIED DRUG; UTERUS SPASMOLYTIC AGENT;

ACUTE PRETERM LABOR; AREFLEXIA; BLURRED VISION; BRAIN HEMORRHAGE; CONTINUOUS INFUSION; DELIVERY; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FLUSHING; GASTRITIS; GASTROESOPHAGEAL REFLUX; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PALPITATION; HUMAN; HYPERGLYCEMIA; HYPOTENSION; HYPOXIA; LETHARGY; LOADING DRUG DOSE; LOW DRUG DOSE; LUNG EDEMA; NAUSEA; NECROTIZING ENTEROCOLITIS; NEWBORN MORBIDITY; PREMATURE LABOR; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVIEW; SEPSIS; SIDE EFFECT; TACHYCARDIA; THORAX PAIN; TOCOLYSIS; TREMOR; URINE VOLUME; UTERUS CONTRACTILITY; VASODILATATION; VOMITING;

CALCIUM CHANNEL BLOCKERS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GESTATIONAL AGE; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; MAGNESIUM COMPOUNDS; NIFEDIPINE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY, HIGH-RISK; TOCOLYSIS; TOCOLYTIC AGENTS; UNITED STATES;

EID: 84857395713     PISSN: 08898545     EISSN: 15580474     Source Type: Journal    
DOI: 10.1016/j.ogc.2011.12.003     Document Type: Review

References (64)

1. Blumenfeld Y., Lyell D. Prematurity prevention: the role of acute tocolysis. Curr Opin Obstet Gynecol 2009, 21:136-141.
2. Roos C., Scheepers L.H., Bloemenkamp K.W., et al. Assessment of perinatal outcome after sustained tocolysis in early labour (APOSTEL-II trial). BMC Pregnancy Childbirth 2009, 9:42.
3. Goldenberg R.L., Culhane J.F., Iams J.D., et al. Epidemiology and causes of preterm birth. Lancet 2008, 371:75-84.
4. Mercer B.M., Goldenberg R.L., Moawad A.H., et al. The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 1999, 181:1216-1221.
5. Da Fonseca E.B., Bittar R.E., Carvalho M.H., et al. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003, 188:419.
6. Meis P.J., Klebanoff M., Thom E., et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003, 348:2379-2385.
7. Goldenberg R.L., Hauth J.C., Andrews W.W. Intrauterine infection and preterm delivery. N Engl J Med 2000, 342:1500-1507.
8. Gyetvai K., Hannah M.E., Hodnett E.D., et al. Tocolytics for preterm labor: a systematic review. Obstet Gynecol 1999, 94:869-877.
9. Macones G.A., Bader T.J., Asch D.A. Optimising maternal-fetal outcomes in preterm labour: a decision analysis. Br J Obstet Gynaecol 1998, 105:541-550.
10. Morgan M.A., Goldenberg R.L., Schulkin J. Obstetrician-gynecologists' screening and management of preterm birth. Obstet Gynecol 2008, 112:35-41.
11. Steer C.M., Petrie R.H. A comparison of magnesium sulfate and alcohol for the prevention of premature labor. Am J Obstet Gynecol 1977, 129:1-4.
12. Elin R.J. Magnesium: the fifth but forgotten electrolyte. Am J Clin Pathol 1994, 102:616-622.
13. Wolf F.I., Torsello A., Fasanella S., et al. Cell physiology of magnesium. Mol Aspects Med 2003, 24:11-26.
14. Fomin V.P., Gibbs S.G., Vanam R., et al. Effect of magnesium sulfate on contractile force and intracellular calcium concentration in pregnant human myometrium. Am J Obstet Gynecol 2006, 194:1384-1390.
15. Phillippe M. Cellular mechanisms underlying magnesium sulfate inhibition of phasic myometrial contractions. Biochem Biophys Res Commun 1998, 252:502-507.
16. Mercer B.M., Merlino A.A. Magnesium sulfate for preterm labor and preterm birth. Obstet Gynecol 2009, 114:650-668. Society for Maternal-Fetal Medicine.
17. Simhan H.N., Caritis S. Inhibition of acute preterm labor Accessed December 8, 2011. http://www.uptodate.com/contents/inhibition-of-acute-preterm-labor.
18. Terrone D.A., Rinehart B.K., Kimmel E.S., et al. A prospective, randomized, controlled trial of high and low maintenance doses of magnesium sulfate for acute tocolysis. Am J Obstet Gynecol 2000, 182:1477-1482.
19. Lyell D.J., Pullen K., Campbell L., et al. Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: a randomized controlled trial. Obstet Gynecol 2007, 110:61-67.
20. Twickler D.M., McIntire D.D., Alexander J.M., et al. Effects of magnesium sulfate on preterm fetal cerebral blood flow using Doppler analysis: a randomized controlled trial. Obstet Gynecol 2010, 115:21-25.
21. Lipsitz P.J. The clinical and biochemical effects of excess magnesium in the newborn. Pediatrics 1971, 47:501-509.
22. Crowther C.A., Hiller J.E., Doyle L.W. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev 2002, 4. CD001060.
23. Crowther C.A., Hiller J.E., Doyle L.W., et al. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA 2003, 290:2669-2676.
24. Marret S., Marpeau L., Bénichou J. Benefit of magnesium sulfate given before very preterm birth to protect infant brain. Pediatrics 2008, 121:225-226.
25. Rouse D.J., Hirtz D.G., Thom E., et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008, 359:895-905.
26. Wesselius-de Casparis A., Thiery M., Yo le Sian A., et al. Results of double-blind, multicentre study with ritodrine in premature labour. Br Med J 1971, 3:144-147.
27. Walters W.A., Wood C. A trial of oral ritodrine for the prevention of premature labour. Br J Obstet Gynaecol 1977, 84:26-30.
28. Lauersen N.H., Merkatz I.R., Tejani N., et al. Inhibition of premature labor: a multicenter comparison of ritodrine and ethanol. Am J Obstet Gynecol 1977, 127:837-845.
29. Terbutaline: label change: warning against use for treatment of preterm labor. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm243843.htm.
30. Simhan H.N., Caritis S.N. Prevention of preterm delivery. N Engl J Med 2007, 357:477-487.
31. Anotayanonth S., Subhedar N.V., Garner P., et al. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev 2004, 4. CD004352.
32. Conde-Agudelo A., Romero R., Kusanovic J.P. Nifedipine in the management of preterm labor: a systematic review and metaanalysis. Am J Obstet Gynecol 2011, 204:134.e1-134.e20.
33. Caritis S.N., Toig G., Heddinger L.A., et al. A double-blind study comparing ritodrine and terbutaline in the treatment of preterm labor. Am J Obstet Gynecol 1984, 150:7-14.
34. Golichowski A.M., Hathaway D.R., Fineberg N., et al. Tocolytic and hemodynamic effects of nifedipine in the ewe. Am J Obstet Gynecol 1985, 151:1134-1140.
35. Groome L.J., Goldenberg R.L., Cliver S.P., et al. Neonatal periventricular-intraventricular hemorrhage after maternal beta-sympathomimetic tocolysis. The March of Dimes Multicenter Study Group. Am J Obstet Gynecol 1992, 167:873-879.
36. Papatsonis D.N., Kok J.H., van Geijn H.P., et al. Neonatal effects of nifedipine and ritodrine for preterm labor. Obstet Gynecol 2000, 95:477-481.
37. Weintraub Z., Solovechick M., Reichman B., et al. Effect of maternal tocolysis on the incidence of severe periventricular/intraventricular haemorrhage in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2001, 85:F13-F17.
38. Ozcan T., Turan C., Ekici E., et al. Ritodrine tocolysis and neonatal intraventricular-periventricular hemorrhage. Gynecol Obstet Invest 1995, 39:60-62.
39. Palta M., Sadek M., Lim T.S., et al. Association of tocolytic therapy with antenatal steroid administration and infant outcomes. Newborn Lung Project. Am J Perinatol 1998, 15:87-92.
40. Nassar A.H., Aoun J., Usta I.M. Calcium channel blockers for the management of preterm birth: a review. Am J Perinatol 2011, 28:57-66.
41. Ferguson J.E., Dyson D.C., Holbrook R.H., et al. Cardiovascular and metabolic effects associated with nifedipine and ritodrine tocolysis. Am J Obstet Gynecol 1989, 161:788-795.
42. King J., Flenady V., Cole S., et al. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev 2005, CD001992.
43. Management of preterm labor. Obstet Gynecol 2003, 101:1039-1047. ACOG Practice Bulletin No. 43.
44. Haas D.M., Imperiale T.F., Kirkpatrick P.R., et al. Tocolytic therapy: a meta-analysis and decision analysis. Am J Obstet Gynecol 2009, 113:585-594.
45. Savage A.H., Anderson B.L., Simhan H.N. The safety of prolonged indomethacin therapy. Am J Perinatol 2007, 24:207-213.
46. Moise K.J., Huhta J.C., Sharif D.S., et al. Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus. N Engl J Med 1988, 319:327-331.
47. Vermillion S.T., Scardo J.A., Lashus A.G., et al. The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. Am J Obstet Gynecol 1997, 177:256-261.
48. Sandruck J.C., Grobman W.A., Gerber S.E. The effect of short-term indomethacin therapy on amniotic fluid volume. Am J Obstet Gynecol 2005, 192:1443-1445.
49. Loe S.M., Sanchez-Ramos L., Kaunitz A.M. Assessing the neonatal safety of indomethacin tocolysis: a systematic review with meta-analysis. Obstet Gynecol 2005, 106:173-179.
50. Akerlund M., Carlsson A.M., Melin P., et al. The effect on the human uterus of two newly developed competitive inhibitors of oxytocin and vasopressin. Acta Obstet Gynecol Scand 1985, 64:499-504.
51. Engstrøm T., Bratholm P., Vilhardt H., et al. Effect of oxytocin receptor and beta2-adrenoceptor blockade on myometrial oxytocin receptors in parturient rats. Biol Reprod 1999, 60:322-329.
52. Coomarasamy A., Knox E.M., Gee H., et al. Oxytocin antagonists for tocolysis in preterm labour: a systematic review. Med Sci Monit 2002, 8:RA268-RA273.
53. Papatsonis D., Flenady V., Cole S., et al. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst Rev 2005, 3. CD004452.
54. Al-Omari W.R., Al-Shammaa H.B., Al-Tikriti E.M., et al. Atosiban and nifedipine in acute tocolysis: a comparative study. Eur J Obstet Gynecol Reprod Biol 2006, 128:129-134.
55. Kashanian M., Akbarian A.R., Soltanzadeh M. Atosiban and nifedipine for the treatment of preterm labor. Int J Gynaecol Obstet 2005, 91:10-14.
56. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study. Acta Obstet Gynecol Scand 2001, 80:413-422. European atosiban Study Group.
57. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. BJOG 2001, 108:133. Worldwide Atosiban versus Beta-agonists Study Group.
58. Goodwin T.M., Millar L., North L., et al. The pharmacokinetics of the oxytocin antagonist atosiban in pregnant women with preterm uterine contractions. Am J Obstet Gynecol 1995, 173:913-917.
59. Valenzuela G.J., Craig J., Bernhardt M.D., et al. Placental passage of the oxytocin antagonist atosiban. Am J Obstet Gynecol 1995, 172:1304-1306.
60. Greig P.C., Massmann G.A., Demarest K.T., et al. Maternal and fetal cardiovascular effects and placental transfer of the oxytocin antagonist atosiban in late-gestation pregnant sheep. Am J Obstet Gynecol 1993, 169:897-902.
61. Moutquin J.M., Sherman D., Cohen H., et al. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am J Obstet Gynecol 2000, 182:1191-1199.
62. Goodwin T.M., Valenzuela G., Silver H., et al. Treatment of preterm labor with the oxytocin antagonist atosiban. Am J Perinatol 1996, 13:143-146.
63. Romero R., Sibai B.M., Sanchez-Ramos L., et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 2000, 182:1173-1183.
64. De Heus R., Mulder E.J., Visser G.H. Management of preterm labor: atosiban or nifedipine?. Int J Womens Health 2010, 2:137-142.